BICO completed the acquisition of QInstruments for $71m.

BICO, a bioconvergence startup that designs and supplies technologies and services to enhance biology research, completed the acquisition of QInstruments, a biotechnology company in Jena, Germany, for $71m. “QInstruments leads the industry by developing beautiful, customer centric, sample preparation tools and technologies that is impacting major research areas and making a difference in the results the customers can achieve. The Acquisition is in line with BICO’s commercial, Bio Convergence strategy, complementing BICO’s product offering through sample preparation by mixing solutions for advanced liquid handling robots and workflows. QInstruments’ innovative product portfolio for mixing solutions for advanced liquid handling can be seamless integrated in our existing workflows and in addition, we also see great potential in integrating QInstruments’ technology in new instruments,” Erik Gatenholm, BICO CEO and Co-Founder.